Science Policy For All

Because science policy affects everyone.

Science Policy Around the Web – November 22, 2012

leave a comment »

photo credit: Jeff Kubina via photopin cc

By: Jennifer Plank

Our weekly linkpost, bringing you interesting and informative links on science policy issues buzzing about the internet.

Hope Delayed for Sharks in Atlantic  The International Commission for the Conservation of Atlantic Tunas recently concluded their annual meeting in Morocco. The ICCAT was founded in 1966 and manages the catch limits of 30 marine species such as tuna, swordfish, and marlins. The group, however, does not set catch limits or manage protections for sharks. This year, conservationists attended the meeting hoping that the ICCAT would include sharks in the list of protected species. While the conservationists failed to obtain new protections for sharks, the commission did agree to open its treaty to changes including shark management. (Erik Stokstad)

New push for most in US to get at least 1 HIV test – The U.S. Preventative Services Task Force (USPSTF) recently set new guidelines recommending that individuals aged 15-64 get at least 1 HIV test. The USPSTF aims for HIV screening to become a routine part of medical visits and to become as common as a doctor ordering a cholesterol test during a physical.  Additionally, if the guidelines set forth by the task force are finalized, the number of patients eligible for HIV screening without a copay will increase. Currently, only individuals at high-risk for HIV- including gay and bisexual men and injecting drug users- are eligible for HIV tests with no co-pay. (Lauran Neergaard)

Makers of diabetes drug will pay $90 million – With increasing numbers of individuals developing diabetes, many pharmaceutical companies are quickly trying to develop new drugs to manage the disease. One company, GlaxoSmithKlein, who manufactures the drug Avandia, will pay $90 million following a settlement suggesting that GSK unlawfully promoted the drug. In 2010, the Senate Finance committee found that the drug was linked to thousands of heart attacks and that GSK knew of the risks for years but did not inform the public of the risks. The $90 million settlement will be distributed among 37 states and the District of Colombia. (Trisha Henry)

Have an interesting science policy link?  Share it in the comments!


Written by sciencepolicyforall

November 22, 2012 at 10:00 am

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: